Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
180 participants
INTERVENTIONAL
2023-11-02
2025-01-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Personalized Normative Feedback to Increase HIV Testing
NCT06969677
Enhancing Communication on Relationship Preservation, Safer Conception and PrEP to Promote HIV Testing in Uganda
NCT06647797
Standardized Patients to Measure and Address Intersectional Stigma
NCT04896216
Reduce Stigma and Improve Treatment Adherence in HIV+ Pregnant Women
NCT03698981
Combating HIV Stigma in Healthcare Settings: A Standardized Patient Approach
NCT06975176
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
V1
As this is a survey experiment, the "intervention" involves random assignment to a survey questionnaire with specific treatments. The first treatment is a questionnaire with questions about internalized stigma followed by questions of experienced stigma. Each question is answered as Yes/No/It depends on knowing more details.
Survey questionnaire V1
Each version of the questionnaire includes a different order of statements about which study participants are asked to provide a Yes, No, or It depends response.
V2
As this is a survey experiment, the "intervention" involves random assignment to a survey questionnaire with specific treatments. The second treatment is a questionnaire with questions about experienced stigma followed by questions about internalized stigma. Each question is answered as Yes/No/It depends on knowing more details.
Survey questionnaire V2
Each version of the questionnaire includes a different order of statements about which study participants are asked to provide a Yes, No, or It depends response.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survey questionnaire V1
Each version of the questionnaire includes a different order of statements about which study participants are asked to provide a Yes, No, or It depends response.
Survey questionnaire V2
Each version of the questionnaire includes a different order of statements about which study participants are asked to provide a Yes, No, or It depends response.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Persons who do not consider Nyakabare Parish their primary place of residence, e.g. persons who happen to be visiting Nyakabare at the time of the survey or who own a home in Nyakabare but spend most of their time outside of the parish
* Persons with psychosis, neurological damage, acute intoxication, or other cognitive impairment (all of which are determined informally in the field by non-clinical research staff in consultation with a supervisor)
* Persons who are not HIV positive
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mbarara University of Science and Technology
OTHER
National Institute of Mental Health (NIMH)
NIH
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alexander Tsai
Associate Professor of Psychiatry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexander C Tsai, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mbarara University of Science and Technology
Mbarara, , Uganda
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013P000395_5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.